---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-245630"
form_type: "8-K"
ticker: "ENOV"
cik: "0001420800"
company_name: "Enovis CORP"
filed_at: "2023-09-28T23:59:59+00:00"
generated_at: "2026-06-10T07:33:34.497653+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Enovis agrees to acquire LimaCorporate for ~€800M enterprise value

## Summary
- Enterprise value ~€800M: ~€700M cash at closing plus 1,942,686 Enovis shares valued at €100M.
- LimaCorporate is a privately held global orthopedic company specializing in digital innovation and custom hardware.
- Closing expected in early 2024, subject to regulatory approvals (including Italian golden power) and other customary conditions.
- Enovis obtained an $800M senior bridge facility commitment from JPMorgan and UBS to finance the acquisition.
- Shares issued to the seller (Emil Holding II) will carry resale registration rights; issued within 18 months post-closing.

## SEC filing metadata
- accession: 0001193125-23-245630
- form_type: 8-K
- ticker: ENOV
- cik: 0001420800
- company_name: Enovis CORP
- filed_at: 2023-09-28T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1420800/000119312523245630/0001193125-23-245630-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1420800/000119312523245630/d439418d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-245630
- JSON: https://secwatch.observer/filing/0001193125-23-245630.json
- Plain text: https://secwatch.observer/filing/0001193125-23-245630.txt

## Key facts
- Material Agreements
  Enovis CORP entered into Share Purchase Agreement with Emil Holding II S.à r.l. valued at Enterprise value of approximately €800 million: ~€700 million cash plus 1,942,686 shares of Enovis c (effective 2023-09-22).
  - Action: entry
  - Agreement: merger
  - Counterparty: Emil Holding II S.à r.l.
  - Value: Enterprise value of approximately €800 million: ~€700 million cash plus 1,942,686 shares of Enovis c
  - Effective: 2023-09-22
  source text: On September 22, 2023, Enovis Corporation (the “Company”) entered into a definitive agreement to acquire LimaCorporate S.p.A. (“Lima”), a privately held global orthopedic company focused on restoring motion through digital innovation and customized hardware.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1420800/000119312523245630/0001193125-23-245630-index.htm
- Material Agreements
  Enovis CORP entered into Commitment Letter with JPMorgan Chase Bank, N.A., UBS AG Stamford Branch, UBS Securities LLC valued at $800 million senior bridge facility and $400 million senior term loan facility (effective 2023-09-22).
  - Action: entry
  - Agreement: credit facility
  - Counterparty: JPMorgan Chase Bank, N.A., UBS AG Stamford Branch, UBS Securities LLC
  - Value: $800 million senior bridge facility and $400 million senior term loan facility
  - Effective: 2023-09-22
  source text: In connection with entering into the Purchase Agreement, on September 22, 2023, the Company entered into a commitment letter (the “Commitment Letter”) with JPMorgan Chase Bank, N.A. (“JPMorgan”), UBS AG Stamford Branch (“UBS AG”), and UBS Securities LLC (“UBS Securities”), pursuant to which JPMorgan and UBS AG agreed to provide a new $800 million senior bridge facility (the “Bridge Facility”) for financing the Acquisition.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1420800/000119312523245630/0001193125-23-245630-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.